PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Quetiapine - Behavioural and Psychological Symptoms of Dementia
PAD Profile : Quetiapine - Behavioural and Psychological Symptoms of Dementia
Keywords :
Non-cognitive symptoms of dementia, BPSD, Alzheimer's Disease, aggression, antipsychotics, anticholinergic burden, aggression, dementia, Schizophrenia, Behavioural and Psychological symptoms of dementia, bipolar, Alzheimer's disease"
Brand Names Include :
Seroquel
Traffic Light Status
Status 1 of 2.
Status :
Blue
Important
Formulations :
- Not Specified
Important Information :
To be initiated by a specialist.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
Additional Documents
Type
Document
Review Date
Guidelines (Local)
01 February 2025
Committee Recommendations
Date
Committee Name
Narrative
01 February 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Integrated Care System Area Prescribing Committee agreed the updated resource pack for use by primary care prescribers for managing non-cognitive symptoms in people living with dementia.
03 May 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
GENERIC Quetiapine has been considered by the PCN and has been assigned a BLUE traffic light status. Note added January 2025 - this drug should be prescribed on initiated by a specialist.
NOTE - the branded product, Seroquel, was considered BLACK at the PCN in May 2017.
Associated BNF Codes
04. Central Nervous System
04.02.01. Antipsychotic drugs